Cambridge Heart, Inc. and Cardiac Science Inc. Launch Nationwide Program to Include MTWA on All New Q-Stress Systems
Published: Jul 12, 2011
TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, announced today that it has reached an agreement with its OEM partner, Cardiac Science Corporation, to include the Company’s proprietary Microvolt T-Wave AlternansTM (MTWA) Module on every new Q-Stress System sale beginning July 11, 2011. The Company expects this initiative to significantly increase the placement of MTWA Modules in coming quarters, which Cambridge Heart anticipates will provide the basis for future recurring revenue.